^
CANCER:
Adrenal Cortex Carcinoma
No biomarker
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
A1
No biomarker
Adrenal Cortex Carcinoma
cisplatin + carboplatin + etoposide IV + mitotane + SGN-15
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
pembrolizumab
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + doxorubicin hydrochloride + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + doxorubicin hydrochloride + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
carboplatin + doxorubicin hydrochloride + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + etoposide IV + mitotane
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
cisplatin + doxorubicin hydrochloride + etoposide IV
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
streptozocin
Sensitive
:
A2
No biomarker
Adrenal Cortex Carcinoma
mitotane + streptozocin
Sensitive
:
A2
MSI-H/dMMR
Adrenal Cortex Carcinoma
pembrolizumab
Sensitive
:
C1
RRM1 underexpression
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
C3
TMB-L
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
C3
MSH2 mutation
Adrenal Cortex Carcinoma
pembrolizumab
Sensitive
:
C4
FGFR3-TACC3 fusion
Adrenal Cortex Carcinoma
erdafitinib
Sensitive
:
C4
TOP2A overexpression
Adrenal Cortex Carcinoma
rubitecan
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
teniposide
Sensitive
:
D
CDK1 overexpression
Adrenal Cortex Carcinoma
carfilzomib + DSP-2033
Sensitive
:
D
CDK4 overexpression
Adrenal Cortex Carcinoma
palbociclib
Sensitive
:
D
TOP2A overexpression
Adrenal Cortex Carcinoma
etoposide oral
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our